Life gets bigger when diabetes management gets smaller. Simplify Life with Omnipod® 5!

Learn more
Omnipod 5 with Pod Omnipod 5 with Pod
Pod shown without the necessary adhesive

The first and only tubeless automated insulin delivery system that works with compatible sensor brands*

Omnipod 5 is the first wearable, tubeless, hybrid closed loop insulin delivery system to integrate with compatible sensors.

Omnipod 5 automatically adjusts insulin delivery every five minutes based on CGM readings, to help protect against highs and lows.1,2 It’s the system that never sleeps!

Already a Podder®? Find everything you need in one place, in your personal user portal.

What is Pod Therapy?

Pod Therapy is simple, tubeless, discreet insulin pump therapy for people living with type 1 diabetes.

Each waterproof, wearable Pod continuously delivers personalised doses of insulin for up to three days (72 hours), controlled wirelessly by you, wherever you are.

With no multiple daily injections and no tubes, Pod Therapy is insulin pump therapy, simplified. Only found with Omnipod®.

Father lifting son in a pool Father lifting son in a pool

Meet our tubeless, wearable Omnipod lineup

UK MMOL no adhesive UK MMOL no adhesive
Pod shown without the necessary adhesive

Omnipod 5 Automated Insulin Delivery System

Experience the freedom of automated insulin delivery and improved time in range1,2 with your preferred glucose sensor.

DASH without adhesive DASH without adhesive
Pod shown without the necessary adhesive

Omnipod DASH® Insulin Management System

You’re in control with the Omnipod DASH® Personal Diabetes Manager. Discover discreet, precise insulin dosing and customisable programmes designed to fit around your lifestyle.

Here’s what our Podders® have to say about Omnipod…

 

Omnipod 5 has allowed me to get a good night sleep. That's the first time I can say that in a long time.

Alvin
Podder since 2017

I don’t have to spend as much time thinking about diabetes.

Clare F.
Podder® since 2013

Let the journey begin...

PEK | Simplify life Omnipod® PEK | Simplify life Omnipod®

Pod Experience Kit

The Pod Experience Kit* contains a real-size, real-weight demo Pod*, without the insulin. It's designed to give you an idea of what it feels like to wear a Pod, and get a sense of how discreet it can be.

The sample Pod is a needle-free, non-functioning Pod. The Controller is not included.

Discover tools and support for navigating
your diabetes journey

Welcome to Pod University

Living with type 1 diabetes can sometimes be daunting. There’s so much to understand when it comes to taking care of your health or that of someone you care about. Pod University serves as your easy-to-navigate online resource for diabetes. It aims to offer you the support and insights you need on various topics, no matter where you are in your journey.

[Attend Pod Uni]

Read a blog!

Diabetes affects individuals from every background and lifestyle. Explore our collection of blog posts created with insights from our community of Podders®. Here, you can find engaging articles that share authentic stories, offering perspectives from those living with diabetes and their caregivers. And more!

[Read a blog]

Speak to an Omnipod Specialist

Still have more questions about the Omnipod System? Enter your information below and one of our Omnipod Specialists will call you in 24-48 hours for a one-to-one chat.

[Connect with a specialist]

OR

[Sign up for a live demo]

1. Brown S. et al. Diabetes Care. 2021;44:1630-1640. Prospective pivotal trial in 240 participants with T1D aged 6 - 70 yrs. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop (HCL) phase. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) in adults/adolescents as measured by CGM: ST = 64.7%, 3-mo Omnipod 5 = 73.9%, P<0.0001. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) in children as measured by CGM: ST = 52.5%, 3-mo Omnipod 5 = 68.0%, P<0.0001. Mean HbA1c: ST vs. Omnipod 5 use in adults/adolescents (14-70 yrs) and children (6-13.9 yrs), respectively (7.16% vs 6.78% or 55 mmol/mol vs. 51 mmol/mol, P<0.0001; 7.67% vs 6.99% or 60mmol/mol vs 53 mmol/mol), P<0.0001. Mean time >10.0 mmol/L or >180mg/dL (12AM-<6AM) as measured by CGM in adults/adolescents and children ST vs. 3-mo Omnipod 5: 32.1% vs. 20.7%; 42.2% vs 20.7%, P<0.0001, respectively. Mean time >10.0 mmol/L or >180mg/dL (6AM-<12AM) as measured by CGM in adults/adolescents and children ST vs. 3-mo Omnipod 5: 32.6% vs. 26.1%; 46.4% vs 33.4%, P<0.0001, respectively. Mean time <3.9 mmol/L or <70 mg/dL (12AM-<6AM) as measured by CGM in adults/adolescents and children ST vs. 3-mo Omnipod 5: 3.64% vs. 1.17%, P<0.0001; 2.51% vs. 1.78, P=0.0456, respectively. Mean time <3.9 mmol/L or <70 mg/dL (6AM-<12AM) as measured by CGM in adults/adolescents and children ST vs. 3-mo Omnipod 5: 2.64% vs. 1.37%, P<0.0001; 2.13% vs. 1.98%, P=0.2545, respectively.
2. Sherr J. et al. Diabetes Care. 2022; 45:1907-1910. Single-arm multicenter clinical trial in 80 pre-school children (aged 2-5.9 yrs) with T1D. Study included a 14-daystandard therapy (ST) phase followed by a 3-month AID phase with Omnipod 5 system. Mean HbA1c as measured in very young children, ST vs. Omnipod 5 use:7.4% vs 6.9% or 57 mmol/ml vs. 53 mmol/mol; (P<0.0001). Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 57.2% vs 68.1%, P<0.0001. Mean time >10.0 mmol/L or >180mg/dL (12AM-<6AM) as measured by CGM in children ST vs. 3-mo Omnipod 5: 38.4% vs. 16.9%, P<0.0001, respectively. Mean time >10.0 mmol/L or >180mg/dL (6AM-<12AM) as measured by CGM in children ST vs. 3-mo Omnipod 5: 39.7% vs. 33.7%, P<0.0001, respectively. Mean time <3.9 mmol/L or <70 mg/dL (12AM-<6AM) as measured by CGM in children ST vs. 3-mo Omnipod 5: 3.41% vs. 2.13%, P=0.0185. Mean time <3.9 mmol/L or <70 mg/dL (6AM-<12AM) as measured by CGM in children ST vs. 3-mo Omnipod 5: 3.44% vs. 2.57%, P=0.0799.
A separate prescription is required for the sensor. The Dexcom G6, Dexcom G7 and FreeStyle Libre 2 Plus sensors are sold separately.
* [Requires Dexcom G6, Dexcom G7 or FreeStyle Libre 2 Plus sensor. Bolus for meals and corrections are still needed.]
† The Pod has an IP28 rating for up to 7.6 metres (25 feet) for 60 minutes. The Omnipod 5 Controller is not waterproof. Please see sensor manufacturer user guide for sensor waterproof rating‡ Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.